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were in the following order: PBS > SUPARTZ® > 1 injection
of Gel-200 ≥ 2 injections of Gel-200. Efficacy of Gel-200 for
suppression of cartilage degeneration was also demonstrated
by a reduction of the increase in chondroitin 6-sulfate (6S) in
the synovial fluid. In addition, Gel-200 appeared to improve the
symptoms of synovitis, as judged from the reduction in increase
of synovial fluid, protein and chondroitin 4-sulfate (4S) contents.
Overall, since cartilage degeneration is milder when synovitis
is not severe, these changes induced by Gel-200 may interact
beneficially to relieve the progression of pathological changes.
Histopathological findings of articular cartilage supported the
morphological assessment. In the histopathological examination
of synovium, cuboidal/stratified synovial epithelium, subepithe-
lial cellular infiltration, subepithelial fibrosis/edema, subepithelial
hemorrhage and subepithelial calcium deposition were observed
in all the experimental groups. These changes were less severe
in Gel-200 groups compared to those in the control group.
Conclusions: These data show that in a rabbit ACL transection
model of OA, a single intra-articular injection of Gel-200 was
superior to five injections of SUPARTZ® in slowing cartilage
degeneration. It is considered that this superiority of Gel-200 is
attributed to its highly cross-linked structure.
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Purpose: The peroxisome proliferator-activated receptor
(PPAR)γ is a known modulator of a number of inflammatory
pathways. Emerging evidence indicates that PPARγ may have
protective effects on structural changes in osteoarthritis (OA). In
this study we evaluated the in vivo therapeutic effect of a PPARγ
agonist, pioglitazone, on the development of structural lesions in
a dog anterior cruciate ligament (ACL) model of OA and explored
the effect of the drug on the major synthetic pathways involved
in the disease process.
Methods: OA was surgically induced in 24 dogs. The OA dogs
were randomly divided into 3 groups (n=8 per group) and treated
orally with either placebo, 15 mg/kg/day of pioglitazone, or 30
mg/kg/day of pioglitazone. The treatment began the day after
surgery and continued for a period of 8 weeks. The severity of
cartilage lesions was scored macroscopically. Cartilage speci-
mens from femoral condyles and tibial plateaus were processed
for histologic evaluation. Both cartilage and synovial membrane
were processed for quantitative RT-PCR and immunohistochem-
istry. Specific probes and antibodies were used to study iNOS,
MMP-1 and ADAMTS-5.
Results: Pioglitazone treatment reduced the development of
cartilage lesions in a dose-dependent manner. There was a
reduction in the lesion scores, and statistical significance was
reached for the medial condyle; p<0.04 and 0.03 respectively for
15 and 30 mg/kg/day of pioglitazone. This decrease correlated
with the cartilage histologic scores. Pioglitazone also significantly
reduced the production of OA key mediators, iNOS, MMP-1 and
ADAMTS-5 in cartilage.
Conclusions: This study demonstrated the efficacy of pioglita-
zone, a PPARγ agonist, at reducing articular lesions in a dog
model of OA. These results provide a new possibility for thera-
peutic intervention in OA, in which in vivo activation of PPARγ
inhibits major cartilage catabolic factors responsible for articular
tissue degradation.
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Purpose: To investigate and compare the characteristics of the
reconstructed articular surface microscopically and histologically
after a time period of 6 weeks following the treatment of a focal
defect of the right femoral head with subchondral drilling and
autologous osteochondral transplantation in rabbits
Methods: A 2,5 mm diameter and 3 mm depth iatrogenic os-
teochondral defect in the anterolateral weight bearing area of
the right femoral head was created in 12 rabbits. In a group of
6 rabbits the lesion was treated with autologous osteochondral
transplantation. The donor site for the transplant was the lat-
eral condyle of the ipsilateral knee joint. The other group of 6
rabbits was treated with subchondral drilling. Both groups were
sacrificed after a time period of 6 weeks and specimens were
evaluated histologically under the classification system of the
ICRS. For statistical analysis we used the Mann - Wittney test
Results: According to the ICRS score statistical significance was
found for all variables between the 2 groups (subchondral drilling
6 weeks vs autologous osteochondral transplantation 6 weeks):
articular surface (p=0,049), matrix (p=0,003), cell distribution (p<
0,0005), subchondral bone (p=0,010), cartilage mineralization
(p=0,0) except cell population viability.
Conclusions: In cases of focal osteochondral defect of the
femoral head in rabbits, reconstruction of the articular surface
through autologous osteochondral graft transplantation gives su-
perior macroscopical and histological results in comparison to
subchondral drilling
P69
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Purpose: Interleukin-1 (IL-1) is thought to play a role in both
the joint destruction seen in osteoarthritis (OA) and the pain that
develops with the disease. The monoiodoacetate (MIA) model of
osteoarthritis in the rat has been used as a model of OA pain
and additionally, displays gross pathology and histologic changes
that resemble some components of OA pathology. This study
therefore uses the MIA model to examine the effect of the IL-1
receptor antagonist (IL-1RA) Anakinra on cartilage degradation
and joint pain.
Methods: 20 male Lewis rats of 7 weeks of age were randomized
into 2 experimental groups of n=10. The rats were then implanted
with Alzet osmotic pumps (model 2ML) containing either vehicle
(PBS) or IL-1RA at a dose of 90mg/kg per day. Three days
after osmotic pump implantation the right knees of each rat
were injected with 0.3mg of MIA in 50ul of saline and the
left knees with 50ul of saline. 6 rats from each group were
then measured for pain on days 1, 2, 3,8,10 and 14 post MIA
injection by incapacitance testing. This measures the difference
in paw weight bearing between the MIA and saline injected
